4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

532.22p
   
  • Change Today:
      54.22p
  • 52 Week High: 1,185.00
  • 52 Week Low: 470.00
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 735
  • Market Cap: £82.70m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
02-Oct-25 RBC Capital Markets Outperform 775.00p 1,600.00p 1,600.00p Reiteration
13-Mar-25 RBC Capital Markets Outperform 1,115.00p - 1,600.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

4basebio Market Data

Currency UK Pounds
Share Price 532.22p
Change Today 54.22p
% Change 11.34 %
52 Week High 1,185.00
52 Week Low 470.00
Volume 735
Shares Issued 15.54m
Market Cap £82.70m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 25-Mar-2026

Time Volume / Share Price
08:51 0 @ 470.00p
08:16 305 @ 506.00p
08:15 197 @ 506.00p
08:10 225 @ 506.00p
08:03 8 @ 506.00p

4basebio Key Personnel

CFO David John Roth
CEO Amy Walker
COO Scott Lorimer

Top of Page